Eculizumab for salvage treatment of refractory antibody-mediated rejection in kidney transplant patients: case reports.
about
Complement cascade and kidney transplantation: The rediscovery of an ancient enemyBiologics in renal transplantationThe Complement System and Antibody-Mediated Transplant RejectionDifferential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B CellsMonitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders.IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury.Complement activation and effect of eculizumab in scleroderma renal crisis.Novel immunosuppressive agents in kidney transplantationComplement inhibition as potential new therapy for antibody-mediated rejection.Antibodies Against Complement Components: Relevance for the Antiphospholipid Syndrome-Biomarkers of the Disease and Biopharmaceuticals.Use of polyclonal/monoclonal antibody therapies in transplantation.Acute antibody-mediated rejection in ABO-compatible pediatric liver transplant recipients: case series and review of the literature.Eculizumab for the Treatment of Severe Antibody-Mediated Rejection: A Case Report and Review of the Literature.Off-label use of the expensive orphan drug eculizumab in France 2009-2013 and the impact of literature: focus on the transplantation field.Late kidney dysfunction in a kidney transplant recipientPlasmapheresis-resistant acute humoral rejection successfully treated with anti-C5 antibody.Pharmacologic Complement Inhibition in Clinical Transplantation.Eculizumab Salvage Therapy for Antibody-Mediated Rejection in a Desensitization-Resistant Intestinal Re-Transplant Patient.
P2860
Q26829790-277AFED8-D69B-47CB-9215-5F33FCC81F05Q27009997-F3A7B1B4-E32D-4CE8-9291-E53E51F5109DQ28087773-9388DFE6-D098-41D8-B056-2629C916E54FQ30279164-27973B77-9CC8-4139-AF04-2B620C08BFBEQ33436307-2760DB1A-6867-4474-800C-0B0A093E9D10Q36417907-38E65E8D-5261-4E39-9CE3-8270FA046049Q37605730-0EFB1160-C491-4E15-A34B-51231772E94AQ38176005-741CE434-F575-45EC-8342-C66B73EC9485Q38609238-AA259C00-C792-484D-B3A6-B83564FE031BQ38718092-276726E6-EE23-48CF-A734-C906B3C8CE94Q38769922-2D791AD7-67A9-4AC2-8920-BCD40BC1892AQ38824123-3EEA538D-A094-41E3-84A1-873AA2055699Q38914719-8F057449-2A00-4E95-9425-8909536D0A9AQ39968188-B50C2FEF-98B1-4E59-9094-2DF40CD2CB6FQ41834576-44742CCB-D404-45FA-8738-FA99A60B7C4FQ45736192-DABADBEC-D56F-4991-9B66-10B4117B5A28Q47104714-8B7B7EBC-F3A3-446A-8B54-1B1F6E6734B3Q53627040-174372C6-E998-4E54-899C-A393B0A644EE
P2860
Eculizumab for salvage treatment of refractory antibody-mediated rejection in kidney transplant patients: case reports.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Eculizumab for salvage treatme ...... splant patients: case reports.
@en
Eculizumab for salvage treatme ...... splant patients: case reports.
@nl
type
label
Eculizumab for salvage treatme ...... splant patients: case reports.
@en
Eculizumab for salvage treatme ...... splant patients: case reports.
@nl
prefLabel
Eculizumab for salvage treatme ...... splant patients: case reports.
@en
Eculizumab for salvage treatme ...... splant patients: case reports.
@nl
P2093
P1476
Eculizumab for salvage treatme ...... splant patients: case reports.
@en
P2093
E Demiralp
M Kalayoglu
M Uzunalan
P304
P356
10.1016/J.TRANSPROCEED.2013.02.062
P407
P577
2013-04-01T00:00:00Z